Psoriasis Treatment Market Players:
- LEO Pharma A/S
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Amgen Inc.
- UCB S.A.
- Merck & co. Inc.
- Evelo Biosciences Inc.
- Sun Pharmaceutical Industries ltd.
- Johnson & Johnson Services Inc.
- Navartis AG
- AbbVie Inc.
- Pfizer Inc.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of psoriasis treatment is estimated at USD 36.04 billion.
The global psoriasis treatment market size was more than USD 33.28 billion in 2025 and is anticipated to grow at a CAGR of around 9.2%, reaching USD 80.24 billion revenue by 2035.
North America psoriasis treatment market will secure around 39.4% share by 2035, driven by the rising long-term investment and advanced healthcare facilities.
Key players in the market include LEO Pharma A/S, Amgen Inc., UCB S.A., Merck & co. Inc., Evelo Biosciences Inc., Sun Pharmaceutical Industries ltd., Johnson & Johnson Services Inc., Navartis AG, AbbVie Inc., Pfizer Inc.
